| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | LOC202051 |
| Uniprot No | 0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-188aa |
| 活性数据 | MATPLGWSKAGSGSVCLALDQLRDVIESQEELIHQLRNVMVLQDENFVSKEEFQAVEKKLVEEKAAHAKTKVLLAKEEEKLQFALGEVEVLSKQLEKEKLAFEKALSSVKSKVLQESSKKDQLITKCNGRREARALHHGYINGLFPNHPVPVSKAGFHSNTCPQLRIQAGPGGPHLRKGLKGPGRPRK |
| 分子量 | 47.2 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是基于假设的重组人LOC202051蛋白相关文献示例(实际文献需在数据库中验证)：
1. **文献名称**: *Expression and Functional Analysis of Recombinant Human LOC202051 in Cancer Cell Lines*
**作者**: Zhang L, et al.
**摘要**: 该研究在大肠杆菌中成功表达重组人LOC202051蛋白，并验证其通过调控MAPK信号通路抑制结直肠癌细胞增殖的机制。
2. **文献名称**: *Structural Characterization of LOC202051: A Novel Protein with Potential Roles in Neurodegeneration*
**作者**: Kim S, Patel R.
**摘要**: 利用X射线晶体学解析LOC202051的三维结构，发现其具有独特的底物结合域，提示其可能参与阿尔茨海默病相关蛋白的代谢通路。
3. **文献名称**: *LOC202051 Recombinant Protein as a Biomarker for Autoimmune Diseases*
**作者**: Gupta M, et al.
**摘要**: 发现重组LOC202051在类风湿关节炎患者血清中高表达，体外实验表明其可能通过调节T细胞活性参与自身免疫反应。
4. **文献名称**: *Optimizing the Production of Recombinant Human LOC202051 in Mammalian Cells*
**作者**: Wang Y, et al.
**摘要**: 开发了一种在HEK293细胞中高效表达LOC202051的重组蛋白技术，并证实其糖基化修饰对蛋白稳定性的关键作用。
**提示**：LOC202051研究可能较少，建议通过NCBI Gene或UniProt核实最新命名(如是否已命名如XX蛋白)，并结合关键词“重组表达”或“功能研究”扩大检索范围。
**Background of Recombinant Human LOC202051 Protein**
The human *LOC202051* gene, also cataloged under alternative identifiers (e.g., UniProt/Swiss-Prot entry), encodes a protein whose biological role remains under active investigation. Although functional annotations are limited, bioinformatic analyses suggest potential involvement in cellular signaling, metabolic regulation, or interactions with other biomolecules, inferred from conserved domains or homology to characterized proteins. Its expression has been detected in various tissues, though specificity and abundance patterns require further validation.
Recombinant human LOC202051 protein is typically produced using heterologous expression systems (e.g., *E. coli*, mammalian cells, or yeast) to enable biochemical and functional studies. Purification methods often involve affinity tags (e.g., His-tag) for efficient isolation. This engineered protein serves as a critical tool for elucidating its structure, enzymatic activity (if applicable), binding partners, or role in diseases. Preliminary studies may link it to pathologies such as cancer or metabolic disorders, though mechanistic insights are sparse.
Current research emphasizes characterizing its subcellular localization, post-translational modifications, and interaction networks. The lack of comprehensive data highlights its status as a protein of interest in exploratory proteomics and molecular biology. Further work is essential to define its physiological significance and potential as a therapeutic target or diagnostic marker.
×
